This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics

SAVINGS DEADLINE EXPIRES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Adam Mendelsohn, Ph.D.
Chief Executive Officer at Vivani Medical
Speaker

Profile

Dr. Mendelsohn has served as a member of the Vivani Medical Board and the Chief Executive Officer since the company’s merger was completed in August 2022. Prior to the merger, Dr. Mendelsohn was a co-founder of Nano Precision Medical and its Chairman of the Board and Chief Executive Officer, setting the strategic vision for the company since its inception. Dr. Mendelsohn received his Ph.D. in bioengineering at the UC San Francisco/UC Berkeley Joint Graduate Group in Bioengineering.

Agenda Sessions

  • Developing a Twice-yearly, Miniaturized Subdermal GLP-1 Delivery Implant

    4:30pm